Nothing Special   »   [go: up one dir, main page]

NO873860D0 - Ifosfamid-lyofilisat og fremgangsmaate til deres fremstilling. - Google Patents

Ifosfamid-lyofilisat og fremgangsmaate til deres fremstilling.

Info

Publication number
NO873860D0
NO873860D0 NO873860A NO873860A NO873860D0 NO 873860 D0 NO873860 D0 NO 873860D0 NO 873860 A NO873860 A NO 873860A NO 873860 A NO873860 A NO 873860A NO 873860 D0 NO873860 D0 NO 873860D0
Authority
NO
Norway
Prior art keywords
ifosphamide
lyophilizate
procedure
preparation
ifosfamide
Prior art date
Application number
NO873860A
Other languages
English (en)
Other versions
NO873860L (no
Inventor
Dieter Sauerbier
Uwe-Peter Dammann
Otto Isaac
Original Assignee
Asta Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Pharma Ag filed Critical Asta Pharma Ag
Publication of NO873860D0 publication Critical patent/NO873860D0/no
Publication of NO873860L publication Critical patent/NO873860L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Control Of El Displays (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Amplifiers (AREA)
  • Indole Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO873860A 1986-10-31 1987-09-15 Ifosfamid-lyofilisat og fremgangsmaate til deres fremstilling. NO873860L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3637089 1986-10-31

Publications (2)

Publication Number Publication Date
NO873860D0 true NO873860D0 (no) 1987-09-15
NO873860L NO873860L (no) 1988-05-02

Family

ID=6312873

Family Applications (1)

Application Number Title Priority Date Filing Date
NO873860A NO873860L (no) 1986-10-31 1987-09-15 Ifosfamid-lyofilisat og fremgangsmaate til deres fremstilling.

Country Status (25)

Country Link
EP (1) EP0265812B1 (no)
JP (1) JPS63159319A (no)
KR (1) KR900003491B1 (no)
AT (1) ATE55250T1 (no)
AU (1) AU598602B2 (no)
CA (1) CA1314231C (no)
DD (1) DD262582A5 (no)
DE (1) DE3764235D1 (no)
DK (1) DK169308B1 (no)
EG (1) EG18333A (no)
ES (1) ES2017982B3 (no)
FI (1) FI87140C (no)
GE (1) GEP19971025B (no)
GR (1) GR3000708T3 (no)
HU (1) HU197987B (no)
IL (1) IL84312A (no)
IN (1) IN168119B (no)
LV (1) LV10051B (no)
MX (1) MX8958A (no)
NO (1) NO873860L (no)
PT (1) PT86032B (no)
RU (1) RU1836079C (no)
UA (1) UA11075A (no)
YU (1) YU197387A (no)
ZA (1) ZA878183B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE65402T1 (de) * 1988-03-19 1991-08-15 Asta Pharma Ag Ifosfamid-mesna-lyophilisat und verfahren zu dessen herstellung.
US5227373A (en) * 1991-10-23 1993-07-13 Bristol-Myers Squibb Co. Lyophilized ifosfamide compositions
WO1995007083A1 (en) * 1993-09-10 1995-03-16 F.H. Faulding & Co. Limited Ifosfamide lyophilisate composition
DE19529057B4 (de) * 1995-08-08 2007-12-13 Baxter Healthcare S.A. Ifosfamid-Lyophilisat-Zubereitungen
TR200002543T2 (tr) * 1998-03-03 2000-11-21 Shionogi & Co., Ltd. Fosfolipaz önleyici sodyum [[3-(2-amino-1,2-dioksietil-1-fenilmetil) -2-etil-1-fenilmetil)- 1H-indol-4-il]oksi] asetat içeren farmasötik kompozisyonlar
EA008776B1 (ru) * 2002-09-05 2007-08-31 Бхарат Сирумс Энд Вэксинс Лтд. Жидкая стабильная композиция оксазафосфорина с месной
JP4611029B2 (ja) * 2002-12-02 2011-01-12 ブハラット セルムズ アンド ヴァクシンズ リミテッド 非経口投与用のイホスファミド組成物及びその製造方法
US8436190B2 (en) * 2005-01-14 2013-05-07 Cephalon, Inc. Bendamustine pharmaceutical compositions
PT2071917E (pt) * 2006-09-29 2013-03-04 Infa Sa Sistema de acondicionamento para composições farmacêuticas e jogo para administração intravenosa
CN105900385B (zh) * 2014-12-04 2019-08-27 华为技术有限公司 在数据通信网中的负载分配

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3732340A (en) * 1966-07-11 1973-05-08 Asta Werke Ag Chem Fab N',o-propylene phosphoric acid ester diamides
DE2750207A1 (de) * 1977-05-09 1978-11-16 Walton J Smith Gefriergetrocknete zusammensetzungen, insbesondere gefriergetrocknete pharmazeutische praeparate und verfahren zu deren herstellung
DE3279834D1 (en) * 1981-12-31 1989-08-31 Asta Pharma Ag 4-sulfido-oxaza phosphorines and their use in the treatment of cancer, and in immunosuppression
US4537883A (en) * 1982-11-12 1985-08-27 Mead Johnson & Company Lyophilized cyclophosphamide

Also Published As

Publication number Publication date
DK569687D0 (da) 1987-10-30
PT86032A (de) 1987-11-01
ATE55250T1 (de) 1990-08-15
EG18333A (en) 1993-12-30
AU598602B2 (en) 1990-06-28
HUT44932A (en) 1988-05-30
IL84312A (en) 1991-11-21
FI874727A0 (fi) 1987-10-27
ZA878183B (en) 1988-05-02
LV10051B (en) 1995-06-20
RU1836079C (ru) 1993-08-23
PT86032B (pt) 1990-08-31
EP0265812B1 (de) 1990-08-08
KR880004814A (ko) 1988-06-27
DK169308B1 (da) 1994-10-10
LV10051A (lv) 1994-05-10
DE3764235D1 (de) 1990-09-13
UA11075A (uk) 1996-12-25
JPS63159319A (ja) 1988-07-02
GEP19971025B (en) 1997-04-06
MX8958A (es) 1993-12-01
DD262582A5 (de) 1988-12-07
FI87140C (fi) 1992-12-10
FI87140B (fi) 1992-08-31
IL84312A0 (en) 1988-03-31
HU197987B (en) 1989-07-28
EP0265812A1 (de) 1988-05-04
FI874727A (fi) 1988-05-01
GR3000708T3 (en) 1991-10-10
IN168119B (no) 1991-02-09
ES2017982B3 (es) 1991-03-16
CA1314231C (en) 1993-03-09
AU8052987A (en) 1988-05-05
YU197387A (en) 1988-12-31
DK569687A (da) 1988-05-01
KR900003491B1 (ko) 1990-05-21
JPH0543684B2 (no) 1993-07-02
NO873860L (no) 1988-05-02

Similar Documents

Publication Publication Date Title
NO900528D0 (no) Anthelmintika, fremgangsmaate for fremstilling derav, og preparat med et innhold derav.
PT90030A (pt) Processo para a preparacao de liofilisado de ifosfamida e mesna
DK11992D0 (da) Epipodophyllotoxinglycosid-4'-phosphatderivater, deres fremstilling og anvendelse
NO172344C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte flavonoidforbindelser og salter
SE8603582L (sv) Komposition innehallande l-dopa
NO873860D0 (no) Ifosfamid-lyofilisat og fremgangsmaate til deres fremstilling.
NO880473L (no) Fremgangsmaate til fremstilling av substituerte 3,4-dihydro-2h-benzopyraner og deres anvendelse som legemiddel.
NO874892D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-(omega-(3,5-di-t-butyl-4-hydroxyfenyl)-alkanoyl)-pyrroler og deres deoxy-analoger.
DK103987A (da) Substituerede 1,3,4,9-tetrahydropyranooe3,4-baaindol-l-eddikesyrer, deres fremstilling og anvendelse som laegemidler
DK422488D0 (da) Arylpyrroler, fremgangsmaader til deres fremstilling samt deres anvendelse som insecticider, acaricider og nematodicider
NO871481L (no) Substituerte tiacykloalkeno(3,2-b)pyridiner og fremgangsmaate for deres fremstilling.
NO883520D0 (no) Fremgangsmaate for fremstilling av et injeksjonspreparat.
DK497888D0 (da) N-(substitueret alkyliden)-1,2,3,4-tetrahydro-9-a cridinaminer, deres fremstilling og anvendelse
NO892087D0 (no) Fremgangsmaate for fremstilling av nye avermectiner med enspaltet furanring og en 8alfa -hydroxygruppe.
NO872885L (no) 1,3,5-tritianderivater og fremgangsmŸte for deres fremstilling.
NO880639D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive oksimetere av 2,6-dioksabicyklo (3, 3, 0)oktanoner.
NO164539C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt 5-nafthyl-2,4-dimethyl-3h-1,2,4-triazol-3-thion.
NO912745L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,2,5,6-tetrahydropyridinforbindelser.
ATE75613T1 (de) 17-benzylspartein-derivate enthaltende positiv inotrop wirksame pharmazeutische zubereitungen.